ArticlePloS one2022

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.

Archana Bommi-Reddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.